(19)
(11) EP 4 798 614 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883338.6

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
A61K 47/68(2017.01)
A61K 35/17(2025.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/705; C07K 14/70539; C07K 14/70503; C07K 2319/00
(86) International application number:
PCT/US2024/052832
(87) International publication number:
WO 2025/090779 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 GB 202316281

(71) Applicant: Replay Holdings, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • WALDMANN, Herman
    San Diego, CA 92121 (US)
  • BUCKLE, Ashley
    San Diego, CA 92121 (US)
  • PARK, Jooyoung
    San Diego, CA 92121 (US)
  • WOOLFSON, Adrian
    San Diego, CA 92121 (US)

(74) Representative: HGF 
HGF Limited 4th Floor, 1 City Square
Leeds LS1 2ES
Leeds LS1 2ES (GB)

   


(54) RECOMBINANT PROTEIN COMPRISING HUMAN LEUKOCYTE ANTIGEN (HLA) AND HLA BINDING PEPTIDE